dr. gunter von minckwitz on pcr and outcomes in breast cancer
Published 11 years ago • 387 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:59
dr. von minckwitz on pathologic complete response in breast cancer
-
1:23
dr. von minckwitz on non-responsive breast cancer patients
-
2:12
dr. von minckwitz on lessons learned from neoadjuvant trials in breast cancer
-
1:01
dr. han on the importance of pcr in breast cancer
-
13:18
sabcs2014: the phase iii ice study (ibandronate) - gunter von minckwitz
-
1:36:34
breast cancer 2022
-
7:26
comprehensive guide to her2-positive breast cancer: stages 1-3 decoded
-
5:33
breast cancer introduction / invasive ductal carcinoma idc / triple negative breast cancer tnbc
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:32
dr. spring on the association between pcr and neoadjuvant chemotherapy
-
1:30
dr. von minckwitz on phase iii results of the aphinity trial for breast cancer
-
1:07
dr. von minckwitz on the safety profile of the aphinity trial for her2 breast cancer
-
16:06
extensive dcis and microcalcifications in patients with breast cancer reaching pcr after nac
-
10:18
gunter von minckwitz: the phase iii natan study (gbg 36/abcsg xx)
-
5:55
utilizing pathologic complete response in breast cancer trials
-
14:05
gunter von minckwitz: selecting the neo-adjuvant treatment by molecular subtype:
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
2:48
dr marc gunter on the importance of breast cancer research in low- and middle-income countries
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
1:54
biosimilars are alternatives for original antibodies
-
20:11
residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer